Alpha Tau Medical Stock Technical Analysis

DRTS Stock  USD 7.47  0.08  1.08%   
Alpha Tau's chart currently indicates trend, momentum, and reversal zones. Higher-timeframe trends provide context for shorter-timeframe signals.
As of the 6th of May, Alpha Tau is marked at 7.47 per share. Recent trend indicators show Mean Deviation of 3.12, risk adjusted performance of 0.0197, and Downside Deviation of 4.62. Trend analytics rely on normalized volatility and volume metrics. Trend metrics are reviewed within historical sector ranges.

Alpha Tau Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Alpha Tau, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Alpha Tau
  
Alpha Tau's Momentum analyses are specifically helpful, as they help identify potential trend changes using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Understanding Alpha Tau Medical includes distinguishing between market value and book value, where book value reflects Alpha Tau's accounting equity.
Value and price for Alpha Tau may converge over time but can differ substantially in any given period. For Alpha Tau, key inputs include a P/B ratio of 8.6, and ROE of -61.0%.

What-If Analysis

Backtesting a what-if scenario on Alpha Tau Medical shows how the stock may have behaved if the position had been entered, held, or resized under different historical assumptions. Enterprise value (TTM) is near 603.31 million. The point is not to predict the future from one chart, but to understand how sensitive the trade has been to timing and holding assumptions.
0.00
02/05/2026
 
No Change 0.00  0.0 
In 3 months and 1 day
 
05/06/2026
0.00
Investing  0.00  in Alpha Tau starting February 5, 2026 and holding to today would gain 0.00 in total return. This translates to a 0.0% cumulative return in Alpha Tau on balance across 90 trading days. The competitive set for Alpha Tau includes Cellectis, Alto Neuroscience, Genelux Common, Larimar Therapeutics, AC Immune, DiaMedica Therapeutics, and Amarin PLC. Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercial... More

Alpha Tau Upside and Downside Indicators Dashboard

These indicators describe how Alpha Tau momentum evolves across recent price ranges. The readings quantify how far price has moved within its recent directional range.

Alpha Tau Market Risk Indicators Signals

The risk context for Alpha Tau is expressed through volatility and drawdown-related metrics. Value-at-risk estimates translate volatility into a probability-weighted loss threshold for a given confidence level.
The concept of mean reversion suggests that Alpha Tau's price will eventually return toward its long-run average. Positions sized too aggressively against the trend often suffer sustained losses before reversion occurs in Alpha Tau. The mean reversion framework for Alpha Tau is built on the premise that markets are not perfectly efficient.
Sentiment
Range
LowSentimentHigh
3.157.4711.79
Details
Intrinsic
Valuation
LowIntrinsicHigh
1.966.2810.60
Details
Naive
Forecast
LowNextHigh
2.757.0711.40
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
6.797.678.55
Details
Alpha Tau's financial and valuation profile is evaluated here relative to direct competitors. Alpha Tau's multiples and operating metrics gain context when measured against direct competitors. Growth rates, profitability, and capital efficiency relative to peers frame Alpha Tau's competitive position.

Technical Indicators

Alpha Tau Medical Backtested Returns

Alpha Tau registers a moderate volatility across the specified investment window. It shows an Efficiency (Sharpe) Ratio of 0.0524, quantifying return efficiency across 3 months. Signal processing identified thirty dispersion-based indicators. Please evaluate metrics such as mean deviation of 3.12, risk-adjusted performance of 0.0197, and Downside Deviation of 4.62 to validate implied downside exposure. On a scale of 0 to 100, Alpha Tau holds a performance score of 4. The firm maintains a Beta (Market Sensitivity) of 2.21, which means elevated sensitivity to broad market movements. As the market goes up, DRTS tends to outperform it. However, if the market returns are negative, Alpha Tau tends to underperform.
Auto-correlation
    
  -0.22  

Weak reverse predictability

Serial correlation analysis for Alpha Tau Medical reveals weak reverse predictability across the intervals from 5th of February 2026 to 22nd of March 2026 and from 22nd of March 2026 to 6th of May 2026. The degree of alignment between past and current intervals shapes expectations about Alpha Tau Medical's price persistence. At -0.22, over 22.0% of current Alpha Tau price movement aligns with historical price trajectory. Given that Alpha Tau Medical has negative autocorrelation for the selected time horizon, market participants may evaluate potential contrarian price behavior over comparable future intervals.
Correlation Coefficient-0.22
Spearman Rank Test-0.19
Residual Average0.0
Price Variance0.25
This technical analysis module for Alpha Tau is structured around price and volume data. This approach uses standard technical indicators across price data.
The analysis looks at how Alpha Tau price movement develops over time. Trend signals and pattern behavior define this framework. More Info...

Technical Analysis

Indicator
Time Period
Execute Indicator
This analysis covers thirty-seven data points across the selected time horizon. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Alpha Tau Medical volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Technical Analysis Methodology & Indicators

Technical analysis of Alpha Tau evaluates price structure, momentum, and volatility clustering. Breakout confirmation often requires sustained volume and liquidity depth. Alpha Tau has a market cap of 662.71 million, ROE of -61.0%.

Alpha Tau Medical inputs come from periodic company reporting and market reference feeds and are mapped into a consistent reporting framework.

Editorial review and methodology oversight provided by: Raphi Shpitalnik, Junior Member of Macroaxis Editorial Board

Technical Indicators

Investors following Alpha Tau Medical often rely on technical indicators to test whether price action is supporting continuation, exhaustion, or a possible change in direction. The practical goal is to improve execution quality rather than to suggest that charts alone can predict every move.

May 6, 2026 Daily Trend Indicators

Investors following Alpha Tau Medical often rely on technical indicators to test whether price action is supporting continuation, exhaustion, or a possible change in direction. The practical goal is to improve execution quality rather than to suggest that charts alone can predict every move.

Additional Tools for Alpha Tau Stock Analysis